Michigan, baby formula manufacturing facility could hit store shelves in the U.S.: At least two months."We understand the situation is urgent – getting Sturgis up and running will help alleviate this shortage," the company said in a statement on Wednesday."Subject to [U.S.
Food and Drug Administration] approval, we could restart the site within two weeks," the statement continues. "We would begin production of EleCare, Alimentum and metabolic formulas first and then begin production of Similac and other formulas.
From the time we restart the site, it will take six to eight weeks before product is available on shelves."A general view of the Abbott Healthcare Nutrition plant in Cootehill Co Monaghan. (Photo by Niall Carson/PA Images via Getty Images) The Sturgis plant has been closed since February, when Abbott issued a voluntary recall of certain powdered formulas made at the facility amid an FDA investigation after four complaints that babies who consumed products from the plant became sick from bacterial infections.
Two of the infants died.BABY FORMULA SHORTAGE: WHITE HOUSE WORKING ‘24/7’ TO ADDRESS SUPPLY CRUNCHThe company said Wednesday that "after a thorough review of all available data, there is no evidence to link our formulas to these infant illnesses."In the meantime, pressure has been building for the FDA to do more to address the infant formula shortage.